Biodegradable Nerve Cap with Closed End for Neuroma Prevention

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nerve caps for treating and preventing neuroma symptoms are either non-customizable, non-biodegradable, or have open ends that allow nerve growth through, leading to complications such as discomfort and infection.

Innovation Solution

A biodegradable polymeric nerve cap with a closed end, made from a poly(DL-lactide-co-ε-caprolactone) copolymer with a lactide content of 51-75 mol%, providing mechanical strength and flexibility, and a method to produce and shape the cap using dip-coating and pressing techniques to ensure a secure closure without adhesives.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If synthetic materials are used for nerve caps, then customizability is improved, but biodegradability deteriorates requiring surgical removal

Engineering Contradiction:
ImprovecustomizabilityVSAvoidbiodegradability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent applies parameter changes by selecting specific compositional parameters (lactide content of 51-75 mol%) and structural parameters (tubular geometry with closed end) to create a biodegradable synthetic nerve cap that maintains customizability while achieving biodegradability through controlled material composition

Inventive Principle:
Principle #35Parameter changes

2Reliability

If biological materials are used for nerve caps, then biodegradability is improved, but customizability deteriorates

Engineering Contradiction:
ImprovebiodegradabilityVSAvoidcustomizability
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent uses composite materials by creating a synthetic polymer composition (poly(DL-lactide-co-ε-caprolactone) copolymer) that combines the biodegradability of natural polymers with the customizability of synthetic materials, achieving both properties simultaneously through material composition rather than biological sources

Inventive Principle:
Principle #40Composite materials

3Ease of operation

If nerve cap has two open ends, then ease of installation is improved, but nerve growth through cap deteriorates

Engineering Contradiction:
Improveease of installationVSAvoidprevention of nerve growth
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent applies segmentation by dividing the nerve cap into distinct functional zones: a closed end that prevents nerve growth and an open end that facilitates installation, creating a structure where different segments serve different purposes to resolve the contradiction

Inventive Principle:
Principle #1Segmentation

4Strength

If nerve cap is made rigid, then mechanical strength is improved, but flexibility deteriorates

Engineering Contradiction:
Improvemechanical strengthVSAvoidflexibility
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The patent applies parameter changes by optimizing the chemical composition parameters (lactide content of 51-75 mol%) to achieve the right balance between mechanical strength and flexibility, where the specific copolymer composition provides both structural integrity and tissue compatibility

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP3265142B1Nerve cap and production thereof
Publication Date: 2021.05.26 POLYGANICS IP BV
  • EP3265142B1 patent drawingFigure 1~2
  • EP3265142B1 patent drawingFigure 3

AI summary

The invention is directed to a nerve cap for covering a nerve stump, comprising a tubular body with a closed end and an open end and essentially consisting of biodegradable polymeric material to prevent or treat symptoms caused by neuroma. The polymeric material preferably comprises a poly(DL-lactide-co-ε-caprolactone) copolymer obtained by the copolymerizaton of DL-lactide and ε-caprolactone, which copolymer has a lactide content of 51-75 mol%.